Reducing glycemic spikes can lower inflammation: synthesis of evidence and practical implications

IN BRIEF

• Glycemic spikes and postprandial insulin increases are associated with systemic inflammation signals (e.g., IL-6, CRP) and adverse metabolic outcomes.
• A significant portion of circulating IL-6 can originate from adipose tissue, and its production can be stimulated by insulin. [1][2]
• Diets with a low insulin impact (low glycemic load, rich in fiber/RS, and with attention to protein quality) reduce glycemic fluctuations and show favorable effects on inflammatory markers in several studies. [4][6][7]
• Drugs like statins have demonstrated anti-inflammatory effects (reduction of IL-6-induced CRP synthesis), but they do not eliminate the role of dietary and lifestyle interventions. [8]
• Evidence includes experimental mechanisms, clinical studies, and meta-analyses; however, the dose-response relationship and direct causality remain partial and context-dependent. [3][5]

Abstract: what does science say?

The central concept is that reducing blood glucose excursions and repeated insulin stimuli throughout the day can reduce signals of systemic inflammation. Part of interleukin-6 (IL-6), a mediator that induces hepatic C-reactive protein (CRP) production, is produced by adipose tissue and can be regulated by insulin. Experimental and clinical studies indicate that dietary interventions that lower postprandial glycemic load and increase fiber or resistant starch intake can reduce some inflammatory biomarkers; similarly, epidemiological observations associate higher levels of IL-6/CRP with a greater metabolic risk. The evidence is not uniform: there are differences between observational and experimental studies, dependence on the intensity and duration of the intervention, and an important role of body weight and gut microbiota in mediating the effects.

Main section

Definition and scope of the topic

"Glycemic spikes" refer to transient increases in glycemia after meals; these determine insulin responses of varying magnitude. The sum of daily glycemic excursions and the frequency of insulin stimuli constitute the individual postprandial profile, which can be influenced by meal composition, fiber, protein content, glycemic index/load, and eating habits. The core of the issue is the interaction between glucose metabolism and low-grade inflammation, frequently observed in metabolic syndromes and cardiovascular risk.

What the evidence shows

A pioneering hypothesis proposed in 2005 suggests that low-insulin-stimulus diets may reduce CRP by modulating adipocyte function and IL-6 production [1]. Experimental studies on human adipose tissue have shown that physiological insulin concentrations can increase the expression and release of IL-6 from adipose tissue. [2] Prospective data have linked elevated baseline levels of IL-6 and CRP to a higher risk of developing diabetes [3], while observational analyses show associations between higher post-load glycemia and inflammatory markers [4]. Dietary interventions aimed at reducing postprandial glycemic load — such as low-glycemic load diets, increased fiber, and resistant starches — have shown improvements in inflammatory markers in meta-analyses of RCTs and clinical studies [5][6][7]. In parallel, drugs like statins also appear to inhibit IL-6-induced CRP production at the hepatic level, indicating a pharmacological anti-inflammatory action distinct from metabolic modulation. [8]

Dose, frequency, and context: what matters

The effects depend on the frequency and amplitude of glycemic spikes, body weight, body composition (visceral fat mass), gut microbiota, and duration of exposure. Short-term interventions may observe modest changes in markers; longer interventions or those with qualitative changes (e.g., sustained increase in fiber/resistant starch) show more consistent results on IL-6 and CRP. Furthermore, the reduction in metabolic risk appears to be partially mediated by weight loss in many studies, making it difficult to separate the direct effect of glycemic fluctuations from the indirect effect of weight reduction.

Interpretive limitations

The literature mixes experimental data, laboratory studies, small clinical trials, and meta-analyses with methodological heterogeneity. Many observational associations do not prove direct causality; moreover, metabolic outcomes are influenced by confounders such as overall diet, physical activity, smoking, and comorbidities. For these reasons, practical recommendations must consider the quality of the evidence and individual variability.

What it means in practice

Food choices with an anti-inflammatory logic

Reducing daily glycemic variability is achieved by prioritizing foods with a low glycemic index/load (whole grains, legumes, non-starchy vegetables), increasing dietary fiber intake, and, when appropriate, favoring protein sources that modulate the glycemic response to the meal. Clinical studies suggest that low-glycemic load diets can reduce areas of postprandial insulin response and improve markers like CRP in contexts of weight loss or metabolic control [7]. Furthermore, increased resistant starches and fermentable fiber are associated with mediated reductions in IL-6 and other inflammatory markers in meta-analyses of RCTs. [6]

Attention to measurement and context

Food choices should be personalized: the benefit is not only a function of the individual food but of the total dietary pattern, physical activity level, metabolic status, and long-term adherence. For those taking medications or with chronic conditions, it is necessary to consult a doctor before making substantial changes. Nutritional interventions can support but not replace pharmacological therapies when indicated.

KEY POINTS TO REMEMBER

• At least part of circulating IL-6 comes from adipose tissue, and its production can be influenced by insulin. [2]
• High levels of IL-6 and CRP are associated with metabolic risk and diabetes in prospective studies. [3]
• Diets that reduce postprandial glycemic load show favorable effects on some inflammatory markers; the effect is often related to the duration and overall quality of the intervention. [6][7]
• Statins exert a demonstrated anti-inflammatory action at the hepatic level on IL-6-induced CRP synthesis, but they do not replace dietary and lifestyle measures. [8]

Limitations of the evidence

It is crucial to distinguish observational studies from causal evidence: associations between glycemic spikes, insulinemia, and inflammatory markers may reflect shared pathways (obesity, inactivity) rather than a unique cause-effect relationship. Many interventional trials are short-term, with limited samples and variable biomarker measurements; the presence of confounders (weight loss, changes in caloric intake) complicates interpretation. Meta-analyses synthesize results but are often heterogeneous in design and populations. Therefore, interpretation must be cautious: the evidence supports biological plausibility and practical utility, but not always definitive proof of direct causality.

Editorial conclusion

The convergence of experimental biological mechanisms, clinical observations, and intervention results suggests that limiting daily glycemic fluctuations is a plausible strategy to reduce signals of low-grade inflammation. Practical actions based on foods with a low glycemic impact, increased fiber and resistant starches, and an overall view of the dietary pattern can contribute to this goal. However, clinical decisions must always consider the individual patient, comorbidities, and ongoing therapies: nutrition is a valuable tool, but it must be integrated with clinical evaluation and, when necessary, with evidence-based pharmacological treatments.

Editorial note

This text revisits previously published observations and updates them in light of available evidence. The information provided is for informational purposes only and does not replace the advice of a healthcare professional. For individual therapeutic decisions, it is necessary to consult your doctor.

SCIENTIFIC RESEARCH

1. McCarty MF. Low-insulin-response diets may decrease plasma C-reactive protein by influencing adipocyte function. Med Hypotheses. 2005;64(2):385–387. https://doi.org/10.1016/j.mehy.2004.03.039
2. Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Klarlund Pedersen B. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab. 2004;286(2):E234–E238. https://doi.org/10.1152/ajpendo.00274.2003
3. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. JAMA. 2001;286(3):327–334. https://doi.org/10.1001/jama.286.3.327
4. Ozder A, et al. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes. Scand J Clin Lab Invest. 2013. https://doi.org/10.3109/00365513.2013.798870
5. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a Low-Glycemic Load Diet on Resting Energy Expenditure and Heart Disease Risk Factors During Weight Loss. JAMA. 2004;292(20):2482–2490. https://doi.org/10.1001/jama.292.20.2482
6. Vahdat M, et al. Effects of resistant starch interventions on circulating inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Nutr J. 2020;19:33. https://doi.org/10.1186/s12937-020-00548-6
7. Della Corte K, Perrar I, Penczynski KJ, Schwingshackl L, Herder C, Buyken AE. Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2018;10(5):606. https://doi.org/10.3390/nu10050606
8. Arnaud C, et al. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct anti-inflammatory effects of statins. Arterioscler Thromb Vasc Biol. 2005;25(6):1231–1236. https://doi.org/10.1161/01.ATV.0000163840.63685.0C